- Home
- SATL vs NPCE Comparison
SATL vs NPCE Comparison
Compare SATL & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.51
HOLD
Current Price
$17.08
Company Overview
Basic Information| Metric | SATL | NPCE |
|---|---|---|
| Founded | 2010 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.3M | 514.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | SATL | NPCE |
|---|---|---|
| Price | $4.51 | $17.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $5.00 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 8.8M | 244.8K |
| Earning Date | 11-10-2025 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $14,684,000.00 | ★ $94,864,000.00 |
| Revenue This Year | N/A | $24.82 |
| Revenue Next Year | N/A | $0.77 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 24.08 |
| 52 Week Low | $1.26 | $7.56 |
| 52 Week High | $5.12 | $18.98 |
Technical Indicators
Market Signals| Indicator | SATL | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 80.25 | 58.55 |
| Support Level | $3.28 | $16.20 |
| Resistance Level | $3.83 | $17.55 |
| Average True Range (ATR) | 0.45 | 0.98 |
| MACD | 0.14 | -0.00 |
| Stochastic Oscillator | 95.02 | 73.27 |
Price Performance
Historical Comparison SATL
NPCE
About SATL Satellogic Inc.
Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.